Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors

Author:

Kulagowski Janusz J.12,Blair Wade12,Bull Richard J.12,Chang Christine12,Deshmukh Gauri12,Dyke Hazel J.12,Eigenbrot Charles12,Ghilardi Nico12,Gibbons Paul12,Harrison Trevor K.12,Hewitt Peter R.12,Liimatta Marya12,Hurley Christopher A.12,Johnson Adam12,Johnson Tony12,Kenny Jane R.12,Bir Kohli Pawan12,Maxey Robert J.12,Mendonca Rohan12,Mortara Kyle12,Murray Jeremy12,Narukulla Raman12,Shia Steven12,Steffek Micah12,Ubhayakar Savita12,Ultsch Mark12,van Abbema Anne12,Ward Stuart I.12,Waszkowycz Bohdan12,Zak Mark12

Affiliation:

1. Departments of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United Kingdom

2. Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3